USSTOCK.TODAY
🏛️ Closed for Labor Day
Log in Sign up
🏛️
Trading Halted Since 2026-06-04: Trading has been halted. It may resume, and prices shown reflect the last trading day. The description below is for reference only.
Company overview

What Does SCWorX (WORX) Do? — Comprehensive Look at Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters

Updated May 26, 2026 · First published May 26, 2026

SCWorX (WORX) is a company that specializes in standardizing hospital asset procurement data and providing a healthcare supply chain cloud platform. This report provides an in-depth look at its IT solutions contract performance, forward stock outlook, and a detailed market cap analysis of healthcare information-related stocks.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is SCWorX?

SCWorX is an IT engineering firm that restructures the procurement specification data of medical consumables used by public health authorities and large hospital foundations into a consistent data model. It links fragmented hospital purchasing information into a single cloud portal to ensure procurement transparency.

Its core business is providing a hospital procurement data integration and management platform as a service. It also generates ancillary operating revenue by collecting maintenance fees and consulting commissions tied to medical device unique identifier (UDI) integration.

How does SCWorX make money?
Business SegmentRevenue ShareDescription
Supply Chain Data SolutionsCoreAnnual subscription license fees received for integrating data standardization software with hospital information systems
Data Quality ConsultingSecondaryConsulting commissions for medical device supply chain database cleansing and catalog optimization projects

The current revenue mix is generated from multiple streams, including supply chain software subscriptions from large general hospitals and remote database cleansing service fees. The company is a relatively small-cap IT services provider, making the volume of new supply chain contracts with major medical groups and tight control of selling, general, and administrative (SG&A) expenses critical levers. By optimizing its cloud-based IT platform, it steadily controls data management costs.

📐 SCWorX Market Cap and Company Scale

Its market capitalization stands at $1.2M, and its workforce size is 9 people.

The company sits within the micro-cap segment of the hospital IT network and medical software industry, where capital scale is limited. It is characterized by very high short-term share price volatility, driven by news flow on multi-year supply chain license contracts with major hospital foundations, as well as disclosures of non-compliance with minimum bid price requirements on US exchanges.

Outlook and Share Price Trends for SCWorX

The forward business outlook is closely tied to the pace of US healthcare procurement transparency legislation and the depth of penetration of its cloud data platform into mid-sized hospitals. While the digital demand trend toward hospital supply chain efficiency is a positive factor, intensifying competition with large healthcare IT rivals for market share and the risk of exchange delisting due to non-compliance with Nasdaq listing maintenance requirements are cited as key future share price swing factors.

  • Speed of new data platform sign-ups among major US medical networks and general hospital chains
  • Execution and submission outcomes of private placement capital funding agreements aimed at resolving Nasdaq listing standard violations

⚔️ SCWorX Core Strengths and Risks

Its differentiated data standardization technology for medical supplies databases is a strength, but chronic losses stemming from delays in securing new general hospital contracts and the risk of exchange delisting are weaknesses.

💪 Core Strengths

Data Standardization Platform
It has built proprietary technology that automatically converts hundreds of thousands of fragmented medical device codes into a single unified IT format.
High Customer Retention Rate
Because the data solution is deeply integrated into hospital IT networks, subscriptions tend to renew annually once an initial link-up is completed.
Regulatory Compliance Efficiency
It supports compliance with the US Food and Drug Administration (FDA) Unique Device Identification (UDI) rule, reducing the audit burden on hospitals.

⚠️ Core Risks

Nasdaq Delisting Warning
It is undergoing a listing qualifications review after falling below the Nasdaq minimum bid price requirement, posing liquidity risk to investors.
Healthcare Procurement Budget Cuts
If small and mid-sized hospitals trim their IT infrastructure spending budgets amid an economic downturn, the pace of new license adoption slows.
Encroachment by Large Platforms
If multinational IT companies in the healthcare information industry begin offering data intermediation capabilities in-house, the company's positioning could weaken.

SCWorX Competitors and Related (Beneficiary) Stocks

Companies viewed as direct competitors within the broader healthcare information and IT services industry include MNDR, which operates a mobile health platform; HCTI, which supplies IT network construction solutions; and ZCMD, which handles Chinese healthcare media. Additionally, MGRX, which runs a men's health portal, and ACON, which designs biocomputer chips, are categorized as related stocks.

✅ Investor Checklist for SCWorX

The key investment review items for SCWorX (WORX), which seeks to break into the US smart healthcare distribution IT market with its differentiated hospital procurement data standardization platform, are as follows.

ChecklistItem to VerifyCurrent Status
Data Contract VolumeGrowth in annual data platform sign-ups from US general hospitals and large hospital foundationsGrowth underway
Listing Maintenance ReviewStatus of Nasdaq hearing preparations and financial settlements to resolve the minimum bid price deficiency noticeReview underway
System Maintenance CostsControl of cloud data hosting costs and labor cost rates for IT analytics personnelSteadily controlled

If the signing of new licenses with general hospitals is delayed over the long term, deepening operating losses, or if delisting is finalized following a failed exchange review, there is a risk of significant impairment to investment value.

SCWorX occupies a niche market in hospital supply chain efficiency, but given its persistent losses and delisting threat, it is prudent to approach the stock with staggered, cautious purchases.

1-Year Price Performance
Analyst Consensus
No analyst coverage
Small-cap or newly listed stocks may not have valuation data collected.
52-Week Price Range
$1
Low $1 High $13
vs. low +46.01% vs. high -91.49%

⚔️ SCWorX Core Strengths and Risks

Its differentiated data standardization technology for medical supplies databases is a strength, but chronic losses stemming from delays in securing new general hospital contracts and the risk of exchange delisting are weaknesses.

💪 Core Strengths

Data Standardization Platform
It has built proprietary technology that automatically converts hundreds of thousands of fragmented medical device codes into a single unified IT format.
High Customer Retention Rate
Because the data solution is deeply integrated into hospital IT networks, subscriptions tend to renew annually once an initial link-up is completed.
Regulatory Compliance Efficiency
It supports compliance with the US Food and Drug Administration (FDA) Unique Device Identification (UDI) rule, reducing the audit burden on hospitals.

⚠️ Core Risks

Nasdaq Delisting Warning
It is undergoing a listing qualifications review after falling below the Nasdaq minimum bid price requirement, posing liquidity risk to investors.
Healthcare Procurement Budget Cuts
If small and mid-sized hospitals trim their IT infrastructure spending budgets amid an economic downturn, the pace of new license adoption slows.
Encroachment by Large Platforms
If multinational IT companies in the healthcare information industry begin offering data intermediation capabilities in-house, the company's positioning could weaken.

SCWorX Competitors and Related (Beneficiary) Stocks

Companies viewed as direct competitors within the broader healthcare information and IT services industry include MNDR, which operates a mobile health platform; HCTI, which supplies IT network construction solutions; and ZCMD, which handles Chinese healthcare media. Additionally, MGRX, which runs a men's health portal, and ACON, which designs biocomputer chips, are categorized as related stocks.

Competitors
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
MNDRMNDRMobile health Network Solutions$1.42-7.2%$1.7M-0.1-47.26%-
HCTIHCTIHealthcare Triangle Inc$0.79-7.8%$11.8M-0.1-57.32%-
ZCMDZCMDZhongchao Inc$0.85-3.8%$1.0M-0.0-31.98%-
Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
MGRXMGRXMangoceuticals Inc$0.41+5.3%$8.9M-0.6-94.42%-
ACONACONAclarion Inc$2.35+2.6%$6.8M-0.3-58.97%-

✅ Investor Checklist for SCWorX

The key investment review items for SCWorX (WORX), which seeks to break into the US smart healthcare distribution IT market with its differentiated hospital procurement data standardization platform, are as follows.

ChecklistItem to VerifyCurrent Status
Data Contract VolumeGrowth in annual data platform sign-ups from US general hospitals and large hospital foundationsGrowth underway
Listing Maintenance ReviewStatus of Nasdaq hearing preparations and financial settlements to resolve the minimum bid price deficiency noticeReview underway
System Maintenance CostsControl of cloud data hosting costs and labor cost rates for IT analytics personnelSteadily controlled

If the signing of new licenses with general hospitals is delayed over the long term, deepening operating losses, or if delisting is finalized following a failed exchange review, there is a risk of significant impairment to investment value.

SCWorX occupies a niche market in hospital supply chain efficiency, but given its persistent losses and delisting threat, it is prudent to approach the stock with staggered, cautious purchases.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →